Clenbuterol 40 - Ice Pharmaceuticals

Designed to relieve airflow obstruction, clenbuterol hydrochloride debuted as a non-steroidal bronchodilator with therapeutic applications in asthma care. Its selective stimulation of beta-2 receptors offered effective treatment with minimal cardiac strain. Though widely accepted in international medicine, its lack of FDA approval left it unutilized in American clinical settings. This regulatory gap, however, led to its emergence in sports pharmacology, where its fat-reducing properties gained lasting popularity.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Clenbuterol 40 by Ice Pharmaceuticals, consult with your doctor or healthcare professional.